ebook Munafa Stock Market Course + Intraday & FNO calls  

       

ESPR announcements Esperion Therapeutics, Inc. announcements and dividends declared NASDAQ

Esperion Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Esperion Therapeutics, Inc. ESPR

Esperion Therapeutics, Inc. ESPR listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Esperion Therapeutics, Inc. ESPR

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) came out with a quarterly loss of [CO].05 per share versus the Zacks Consensus Estimate of a loss of [CO].15. This compares to loss of [CO].46 per share a year ago. These figures are adjusted for non-recurri
Announcement as on 12 August 2024

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) came out with a quarterly loss of [CO].05 per share versus the Zacks Consensus Estimate of a loss of [CO].15. This compares to loss of [CO].46 per share a year ago. These figures are adjusted for non-recurri
Announcement as on 12 August 2024

: Esperion Therapeutics stock slumps 22% premarket as data from study of cholestrol-lowering drug fail to impress investors
The stock of Esperion Therapeutics Inc. ESPR slumped 22% in premarket trade Monday, as investors seemed to question whether data from a major study of its cholesterol-lowering drug Nexletol showing it reduced the  risk of heart attacks and some other card
Announcement as on 06 March 2023

Strength Seen in Esperion Therapeutics (ESPR): Can Its 5.7% Jump Turn into More Strength?
Esperion Therapeutics (ESPR) shares soared 5.7% in the last trading session to close at .45. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 2.9% gain over the past four weeks
Announcement as on 16 September 2022

Implied Volatility Surging for Esperion Therapeutics (ESPR) Stock Options
Investors in Esperion Therapeutics, Inc. ESPR need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 21, 2022 .50 Call had some of the highest implied volatility of all equity options today.
Announcement as on 19 November 2021

Announcements by Esperion Therapeutics, Inc. first page | Next page |

ESPR Esperion Therapeutics, Inc. current price & indicator signals

Moving Averages for Esperion Therapeutics, Inc.

  • 5Day Average: 3.74
  • 12Day Average: 3.53
  • 20Day Average: 3.27
  • 50Day Average: 2.98
  • 100Day Average: 2.53
  • 150Day Average: 2.02
  • 200Day Average: 1.86

ESPR Indicators & signals

Indicator MACD (12,26,9)

3.56, 3.29, 0.21
Indicator MACD is in positive zone

Indicator ADX (14)

6.67, 33.33, 29.17
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of ESPR Esperion Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 3.73 3.68 to 3.83 -1.32% 0.43 times
04 Thu Dec 2025 3.78 3.76 to 3.91 0% 0.58 times
03 Wed Dec 2025 3.78 3.61 to 3.85 3% 0.55 times
02 Tue Dec 2025 3.67 3.59 to 3.90 -1.34% 0.66 times
01 Mon Dec 2025 3.72 3.64 to 4.03 -7.23% 0.94 times
28 Fri Nov 2025 4.01 3.88 to 4.02 1.52% 0.62 times
26 Wed Nov 2025 3.95 3.64 to 4.02 7.34% 1.39 times
25 Tue Nov 2025 3.68 3.20 to 3.77 15.72% 2.43 times
24 Mon Nov 2025 3.18 3.04 to 3.20 3.25% 0.67 times
21 Fri Nov 2025 3.08 2.95 to 3.18 4.41% 1.31 times
20 Thu Nov 2025 2.95 2.82 to 3.02 5.73% 0.86 times
19 Wed Nov 2025 2.79 2.74 to 2.84 -1.41% 0.37 times

Videos related to: ESPR announcements Esperion Therapeutics, Inc. announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

ESPR announcements Esperion Therapeutics, Inc. announcements and dividends declared NASDAQ

 

Back to top